Barclays
KMTS

Barclays’s Kestra Medical Technologies KMTS Stock Holding History

Barclays’s Portfolio KMTS Stock Details KMTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$248K Sell
9,752
-7,431
-43% -$156K ﹤0.01% 3583
2026
Q1 		$342K Sell
17,183
-23,987
-58% -$565K ﹤0.01% 3398
2025
Q4 		$1.09M Buy
41,170
+22,507
+121% +$580K ﹤0.01% 3368
2025
Q3 		$443K Sell
18,663
-10,796
-37% -$193K ﹤0.01% 3886
2025
Q2 		$488K Buy
29,459
+21,459
+268% +$468K ﹤0.01% 3769
2025
Q1 		$199K Buy
+8,000
New +$184K ﹤0.01% 4038

Other funds holding KMTS

BCI
Bain Capital Investors Boston, Massachusetts $4.82B AUM 35.43% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
AP
Andera Partners Paris $206M AUM
YF
Yu Fan $108M AUM 137.54% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Barclays's KMTS Position: Q2 2026 in Review

Barclays reduced its Kestra Medical Technologies (KMTS) stake by 43% in Q2 2026, selling an estimated $156K and leaving 9,752 shares worth $248K. The position accounts for ﹤0.01% of the portfolio, ranked #3583.

Barclays first reported a position in KMTS in Q1 2025 and has held it in 6 quarters since. The position peaked at $1.09M in Q4 2025. 108 funds tracked by Wall St. Rank hold KMTS as of Q2 2026.

  • Barclays held 9,752 shares of Kestra Medical Technologies worth $248K as of Q2 2026.
  • Barclays sold 7,431 Kestra Medical Technologies shares in Q2 2026, an estimated $156K.
  • Kestra Medical Technologies made up ﹤0.01% of Barclays's portfolio in Q2 2026, its #3583 holding.
  • Barclays first reported a position in Kestra Medical Technologies in Q1 2025 and has held it in 6 quarters since.
  • Barclays's Kestra Medical Technologies position peaked at $1.09M in Q4 2025.
  • 108 funds tracked by Wall St. Rank held Kestra Medical Technologies as of Q2 2026.

Based on Barclays's 13F filing for Q2 2026, filed 14 Aug 2026.